Kenneth Ray

Kenneth Ray has a strong background in analytical chemistry, with experience working as a Director and Associate Director at Prelude Therapeutics and as a Senior Principal Investigator and Principal Investigator at Incyte. Kenneth has also held positions as a Senior Scientist at Novatia, LLC and as a Research Investigator at Bristol-Myers Squibb. Throughout their career, Kenneth has demonstrated expertise in chromatographic, spectroscopic, and solid state techniques, as well as in resolving issues in small-molecule pharmaceutical development and identifying impurities and degradants.

Kenneth Ray earned their B.A. in Economics from Rice University, completing their education in 1991. Kenneth then pursued further studies at the University of North Carolina at Chapel Hill, where they obtained a Ph.D. in Analytical Chemistry. Kenneth'sdoctoral degree was conferred in the year 2000.